论文部分内容阅读
目的:研究沐舒坦雾化吸入治疗老年慢性支气管炎急性发作的临床效果。方法:2013年9月至2015年9月,选取某院121例老年慢性支气管炎患者作为本研究的研究对象,并将其随机分为对照组60例与研究组61例。对两组患者均采用常规疗法进行治疗,在给予研究组进行沐舒坦雾化吸入治疗。对两组患者的临床治疗效果进行观察并比较。结果:经治疗后,对照组与研究组的总有效率分别显示为76.67%,96.72%,后者明显高于前者(=10.60,P<0.05);对照组的住院时间与症状缓解时间均长于研究组(P<0.05);对照组的FEV1、PaO_2指标低于研究组,PaCO_2指标高于研究组,以上三组差异均存在统计学意义。结论:相比单纯采用常规治疗,沐舒坦雾化吸入治疗联合常规治疗对老年慢性支气管炎急性发作患者进行治疗有着极为显著的治疗效果,该治疗方法不仅能够缩短患者的住院时间与症状缓解时间,而且还能够将其FEV1、PaO_2、PaCO_2指标进行优化,从而将患者的康复速度进行加快。
Objective: To study the clinical effect of mucosolvan inhalation in the treatment of acute episode of senile chronic bronchitis. Methods: From September 2013 to September 2015, 121 elderly patients with chronic bronchitis in a hospital were enrolled in this study. They were randomly divided into control group (60 cases) and study group (61 cases). Both groups of patients were treated with conventional therapies, mucosolvan inhalation was given to the study group. The clinical effects of two groups of patients were observed and compared. Results: After treatment, the total effective rate of the control group and the study group was 76.67% and 96.72% respectively, which was significantly higher than the former (= 10.60, P <0.05); the length of stay and symptom relief in the control group were longer than those in the control group (P <0.05). The FEV1 and PaO2 values in the control group were lower than those in the study group, and the PaCO2 index was higher in the control group than in the study group. The differences among the above three groups were statistically significant. CONCLUSIONS: Mucosolvan inhalation combined with conventional treatment has significant therapeutic effect on the treatment of acute exacerbation of chronic bronchitis in elderly patients. Compared with conventional treatment alone, this treatment not only can shorten the length of hospital stay and symptom relief, But also to optimize its FEV1, PaO2, PaCO2 indicators to speed up the patient’s recovery.